BB Biotech AG (BION.S)
65.75CHF
19 Jul 2019
CHF-1.05 (-1.57%)
CHF66.80
CHF66.75
CHF66.75
CHF65.45
71,947
74,443
CHF74.60
CHF55.05
About
Overall
| Beta: | 1.16 |
| Market Cap(Mil.): | CHF3,731.19 |
| Shares Outstanding(Mil.): | 55.40 |
| Dividend: | 2.75 |
| Yield (%): | 4.08 |
Financials
| BION.S | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 4.38 | 69.41 | 32.67 |
| EPS (TTM): | 15.37 | -- | -- |
| ROI: | 28.44 | 8.94 | 14.49 |
| ROE: | 28.44 | 10.07 | 15.79 |
Italy - Factors to watch on July 19
The following factors could affect Italian markets on Friday.
BRIEF-BB Biotech H1 Net Profit At CHF 554 Mln
* CONSOLIDATION LEAVES A MARK ON RESULTS IN THE SECOND QUARTER
DIARY - Italy to August 31
Inclusion of diary items does not necessarily mean that Reuters will file a story based on the event.
DIARY - Italy to August 31
Inclusion of diary items does not necessarily mean that Reuters will file a story based on the event.
DIARY - Italy to August 31
Inclusion of diary items does not necessarily mean that Reuters will file a story based on the event.
BRIEF-BB Biotech Q1 Profit Of CHF 890 Million
* Q1 PROFIT OF CHF 890 MN (PROFIT OF CHF 28 MN IN CORRESPONDING PERIOD OF PREVIOUS YEAR) Source text for Eikon: Further company coverage: (Gdynia Newsroom)
Swiss stocks - Factors to watch on April 12
ZURICH/BERLIN, April 12 The Swiss blue-chip SMI was seen opening 0.1 percent lower at 9,543 points on Friday, according to premarket indications by bank Julius Baer .
BRIEF-BB Biotech Launches New Buyback Program
* SAID ON THURSDAY CONCLUDES ITS SHARE BUYBACK PROGRAM AND LAUNCHES A NEW BUYBACK PROGRAM
BRIEF-BB Biotech FY Net Result Swings To Loss Of CHF 471 Million
* FY NET LOSS OF CHF 471 MN COMPARED TO A NET GAIN OF CHF 688 MN FOR FULL YEAR OF 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
Estimates